Pacemaker and defibrillator therapy in pediatric and congenital heart disease patients requires highly individualized management due to unique technical issues and complex patient diversity.
Highlights the unique challenges, technical issues, and individualized management required for pacemaker and defibrillator therapy in pediatric and congenital heart disease patients.
Pacemakers and defibrillators have a growing use in pediatrics and in patients with congenital heart disease, but they present unique problems and implications for their implantation and follow-up. Congenital and surgically acquired rhythm disturbances are common, but the efficacy of device therapy is not well established in these patient groups. The diversity and complexity of pediatric patients and congenital heart disease make device management a highly individualized art. There are technical issues related to device implantation that have necessitated novel approaches to using leads and device that were not designed with children specifically in mind. The current guidelines and indications for implantable device therapy for children and congenital heart disease are reviewed, as well as some of the specific limitations and problems encountered.
Terrence Chun (Tue,) conducted a review in Pediatrics and congenital heart disease. Pacemakers and defibrillators was evaluated. Pacemaker and defibrillator therapy in pediatric and congenital heart disease patients requires highly individualized management due to unique technical issues and complex patient diversity.